Balchem Balance Sheet Health
Financial Health criteria checks 6/6
Balchem has a total shareholder equity of $1.3B and total debt of $154.0M, which brings its debt-to-equity ratio to 11.9%. Its total assets and total liabilities are $1.7B and $363.2M respectively. Balchem's EBIT is $205.1M making its interest coverage ratio 18.4. It has cash and short-term investments of $65.1M.
Key information
11.87%
Debt to equity ratio
US$154.00m
Debt
| Interest coverage ratio | 18.4x |
| Cash | US$65.09m |
| Equity | US$1.30b |
| Total liabilities | US$363.17m |
| Total assets | US$1.66b |
Recent financial health updates
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Sep 26
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 23We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Mar 21Recent updates
Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital
Dec 01Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)
Oct 23Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio
Oct 10Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Sep 26Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 26Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital
Jul 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 23When Should You Buy Balchem Corporation (NASDAQ:BCPC)?
May 26Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 17We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Mar 21Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing
Mar 07A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jan 30Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28
Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion
Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.Balchem: A Tale Of Two Businesses
May 10Balchem: Potential Turnaround Is In The Price
Feb 21Financial Position Analysis
Short Term Liabilities: BCPC's short term assets ($343.7M) exceed its short term liabilities ($126.4M).
Long Term Liabilities: BCPC's short term assets ($343.7M) exceed its long term liabilities ($236.8M).
Debt to Equity History and Analysis
Debt Level: BCPC's net debt to equity ratio (6.9%) is considered satisfactory.
Reducing Debt: BCPC's debt to equity ratio has reduced from 24.3% to 11.9% over the past 5 years.
Debt Coverage: BCPC's debt is well covered by operating cash flow (130.9%).
Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (18.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/28 01:48 |
| End of Day Share Price | 2025/12/26 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Balchem Corporation is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Labick | CJS Securities, Inc. |
| Timothy Ramey | D.A. Davidson & Co. |
| Raghuram Selvaraju | H.C. Wainwright & Co. |